Clinical Trial Update: Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating a combination of Gemtuzumab ozogamicin and Midostaurin with standard cytarabine and daunorubicin in newly diagnosed FLT-3 mutated acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)
• Midostaurin (midostaurin)

Snippet

Sponsor: Uma Borate | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED